Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71078 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Minsun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jeonbuk National University Children's Hospital, Jeonju, Korea. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Hypoglycemia, Diabetic Ketoacidosis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hypoglycaemia is a frequent complication during diabetic ketoacidosis (DKA) treatment. Continuous glucose monitoring (CGM) provides real‐time glucose trend information; however, its clinical utility during paediatric DKA management in the intensive care unit (ICU) remains uncertain. We investigated whether CGM insertion during DKA treatment in the paediatric ICU (PICU) is associated with reduced hypoglycaemia and a lower burden of point‐of‐care (POC) glucose measurements. Materials and Methods We conducted a retrospective single‐centre cohort study of paediatric patients (< 20 years) admitted to the PICU with DKA between December 2013 and December 2025 who received continuous intravenous insulin infusion. Patients were categorised based on CGM insertion during their PICU stay. The primary outcome was hypoglycaemia. Secondary outcomes included frequency of POC glucose measurements, ICU length of stay and time to DKA resolution.
Results
Seventy‐three patients were included; 31 (42.5%) underwent CGM insertion. The incidence of hypoglycaemia was significantly lower in the CGM group (glucose < 70 mg/dL: 6.5% vs. 47.6%, p < 0.001; < 60 mg/dL: 0% vs. 21.4%, p = 0.008). In multivariable analysis, CGM insertion was independently associated with lower hypoglycaemia risk (adjusted OR 0.059, 95% CI 0.011–0.323; p = 0.001). The CGM group also had a significantly lower frequency of POC glucose measurements than the control group.
Conclusion
Amongst paediatric patients with DKA treated in the PICU, CGM insertion was independently associated with reduced hypoglycaemia and a lower POC testing burden. Prospective studies are warranted to determine whether CGM‐guided DKA management improves clinical outcomes in critically ill children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Jeonbuk National University Children's Hospital, Jeonju, Korea.
- Department of Pediatrics, Jeonbuk National University Medical School, Jeonju, Korea.
- Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju, Korea.
ORCID-Profile: Esther Park
Zitieren
APA
Kim, M., & Park, E. (2026). Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71078
Vancouver
Kim M, Park E. Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71078
BibTeX
@article{Kim2026,
author = {Kim, Minsun and Park, Esther},
title = {Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71078}
}
EUVIMED